miRNA-711-SP1-collagen-I pathway is involved in the anti-fibrotic effect of pioglitazone in myocardial infarction

Science China Life Sciences

Volumn 56, Issue 5, 2013, Pages 431-439

  Zhao, Na ^a   Yu, HaiYi ^a   Yu, HaiTao ^a   Sun, Min ^a   Zhang, YouYi ^a   Xu, Ming ^a   Gao, Wei ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

cardiac fibrosis; miR 711; pioglitazone

Indexed keywords

RATTUS;

EID: 84876968153     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-013-4477-1     Document Type: Article

References (23)

1. Opie L H, Commerford P J, Gersh B J, et al. Controversies in ventricular remodelling. Lancet, 2006, 367: 356-367.
2. Biswas A, Rabbani S I, Devi K. Influence of pioglitazone on experimental heart failure and hyperlipidemia in rats. Indian J Pharmacol, 2012, 44: 333-339.
3. Kataoka Y, Yagi N, Kokubu N, et al. Effect of pretreatment with pioglitazone on reperfusion injury in diabetic patients with acute myocardial infarction. Circ J, 2011, 75: 1968-1974.
4. Shiomi T, Tsutsui H, Hayashidani S, et al. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation, 2002, 106: 3126-3132.
5. Wayman N S, Hattori Y, Mcdonald M C, et al. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J, 2002, 16: 1027-1040.
6. Yasuda S, Kobayashi H, Iwasa M, et al. Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction. Am J Physiol Heart Circ Physiol, 2009, 296: H1558-H1565.
7. Mohite A J, Chillar A J, Wijaya C, et al. Endogenous prostacyclin signaling regulating microRNA expression in mammalian cells. FASEB J, 2009, 23: LB373.
8. van Rooij E, Sutherland L B, Thatcher J E, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA, 2008, 105: 13027-13032.
9. Cheng K, Malliaras K, Shen D, et al. Intramyocardial injection of platelet gel promotes endogenous repair and augments cardiac function in rats with myocardial infarction. J Am Coll Cardiol, 2012, 59: 256-264.
10. Simpson P, Savion S. Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chronotropic response to isoproterenol. Circ Res, 1982, 50: 101-116.
11. Caglayan E, Stauber B, Collins A R, et al. Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis. Diabetes, 2008, 57: 2470-2479.
12. Zhao S M, Shen L H, Li H W, et al. Down-regulation of the expression of angiotensin II type 1 receptor in neonatal rat cardiac fibroblast by activation of PPARgamma signal pathway. Chin J Physiol, 2008, 51: 357-362.
13. Nakamura T, Yamamoto E, Kataoka K, et al. Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan. Hypertension, 2008, 51: 296-301.
14. Elrashidy R A, Asker M E, Mohamed H E. Pioglitazone attenuates cardiac fibrosis and hypertrophy in a rat model of diabetic nephropathy. J Cardiovasc Pharmacol Ther, 2012, 17: 324-333.
15. Yu Y, Zhang Z H, Wei S G, et al. Peroxisome proliferator-activated receptor-gamma regulates inflammation and renin-angiotensin system activity in the hypothalamic paraventricular nucleus and ameliorates peripheral manifestations of heart failure. Hypertension, 2012, 59: 477-484.
16. Han S, Rivera H N, Roman J. Peroxisome proliferator-activated receptor-gamma ligands inhibit alpha5 integrin gene transcription in non-small cell lung carcinoma cells. Am J Respir Cell Mol Biol, 2005, 32: 350-359.
17. Grohe C, Kahlert S, Lobbert K, et al. Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth. J Hypertens, 1998, 16: 377-384.
18. Redell J B, Liu Y, Dash P K. Traumatic brain injury alters expression of hippocampal microRNAs: potential regulators of multiple pathophysiological processes. J Neurosci Res, 2009, 87: 1435-1448.
19. Wang K, Zhang S, Marzolf B, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA, 2009, 106: 4402-4407.
20. Creemers E E, Pinto Y M. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res, 2011, 89: 265-272.
21. Inagaki Y, Nemoto T, Nakao A, et al. Interaction between GC box binding factors and Smad proteins modulates cell lineage-specific alpha 2(I) collagen gene transcription. J Biol Chem, 2001, 276: 16573-16579.
22. Poncelet A C, Schnaper H W. SP1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells. J Biol Chem, 2001, 276: 6983-6992.
23. Sysa P, Potter J J, Liu X, et al. Transforming growth factor-beta1 up-regulation of human alpha(1)(I) collagen is mediated by SP1 and Smad2 transacting factors. DNA Cell Biol, 2009, 28: 425-434.